Purchase Order 75N91019P00603

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $24,500 on January 28, 2020, for laboratory testing services. Performance is located in Dunbarton, New Hampshire, with an ultimate completion date of December 31, 2020. The contract carries firm fixed pricing with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $2,065.00 on July 21, 2020, with an ultimate completion date of January 15, 2021. The order is for laboratory testing services. Performance will take place in Dunbarton, New Hampshire. Interpflow is a minority-owned and Hispanic American-owned corporation.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $14,875.00 on May 7, 2019. Work is being performed in Doral, Florida and covers laboratory testing, including flow cytometry analysis services. Ultimate completion is scheduled for August 15, 2019. The awardee is a minority-owned and Hispanic American-owned corporation.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $14,875.00 on March 8, 2019. Work is to be performed in Doral, Florida and will complete by April 30, 2019. The order covers laboratory testing services, including flow cytometry analysis and related testing services. Interpflow Corporation is a minority-owned and Hispanic American-owned business.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $14,875.00 on April 10, 2018, for data analysis of flow case (FCS) files, with completion scheduled for May 31, 2018. Work is performed at Bethesda, Maryland. Interpflow is a minority-owned and Hispanic American-owned corporation specializing in flow cytometry analysis services. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $14,875 on August 27, 2018, for data analysis of flow case (FCS) files. Work is performed in Doral, Florida, with an ultimate completion date of October 31, 2018. The awardee is a minority-owned and Hispanic American-owned corporation. Pricing is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Interpflow Corporation for $14,980.00 on August 24, 2017. Work is performed in Doral, Florida. The order covers a maintenance agreement and is firm fixed price with a completion date of December 31, 2017. Interpflow is minority-owned and Hispanic American-owned.</p>

<p>The National Cancer Institute issued a purchase order to Interpflow Corporation valued at $14,875.00, awarded June 28, 2018, with completion by June 30, 2019. No set-aside was used. Performance occurs at Doral, FL 33126. The order procures flow cytometry analysis services, including computer analysis of list mode data files and laboratory testing services. Interpflow is a minority-owned and Hispanic American-owned corporation.</p>

<p>The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $10,212.50 on August 12, 2019, for lab testing services. Performance concludes September 11, 2019, with work performed in Piscataway, New Jersey. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>